BONYF NV is poised to revolutionize dental care with the launch of Periocream, a groundbreaking treatment that promises to transform the management of dental procedures.

BONYF NV reaffirms its long-term vision and growth strategy despite experiencing short-term market volatility and a decline in its share price.

BONYF NV, a leader in dental care innovation, has released its 2024 annual results, highlighting key highlights such as patented formulations, quality production, and global presence.

BONYF NV has partnered with Group Pharmaceuticals, a leading Indian oral health company, to drive growth in the Indian market through a 13.5% stake acquisition and local production of BONYF’s products.

BONYF NV has announced its entry into the US market through a strategic partnership with Honest Pharma, marking a significant milestone in its global expansion and bringing its innovative oral care products to the US market.